Advanced Medical Solutions Group plc (AMS) is a medical technology company, that designs, manufactures and distributes wound care dressings and medical adhesives for closing wounds and sealing tissues. It develops products utilizing wide range of technology platform. The company’s products include tissue adhesives, collagen, sutures, oxidized cellulose, internal fixation, alginate sealants, bone substitutes, alginates, fibers, foams, hydrocolloid, hydrogels, and antimicrobial dressings. These products are supplied through major wound care partners and private label distributors. The company operates in the UK, the Netherlands, France, Germany, Czech Republic, Israel and Russia. AMS is headquartered in Winsford, Cheshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Advanced Medical Solutions Group Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Advanced Medical Solutions Group Plc Company Overview
- Advanced Medical Solutions Group Plc Company Snapshot
- Advanced Medical Solutions Group Plc Pipeline Products and Ongoing Clinical Trials Overview
- Advanced Medical Solutions Group Plc - Pipeline Analysis Overview
- Business Description
- Advanced Medical Solutions Group Plc - Key Facts
- Advanced Medical Solutions Group Plc - Major Products and Services
- Advanced Medical Solutions Group Plc Pipeline Products by Development Stage
- Advanced Medical Solutions Group Plc Ongoing Clinical Trials by Trial Status
- Advanced Medical Solutions Group Plc Pipeline Products Overview
- Biological Graft
- Biological Graft Product Overview
- Dental Collagen
- Dental Collagen Product Overview
- Gene-Activated Matrix
- Gene-Activated Matrix Product Overview
- Hydrogel
- Hydrogel Product Overview
- Large Wounds Closure Device
- Large Wounds Closure Device Product Overview
- LiquiBand
- LiquiBand Product Overview
- LiquiBand Clinical Trial
- LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device
- LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device Product Overview
- LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device Clinical Trial
- LIQUIFIX Precision Open Hernia Mesh Fixation Device
- LIQUIFIX Precision Open Hernia Mesh Fixation Device Product Overview
- LIQUIFIX Precision Open Hernia Mesh Fixation Device Clinical Trial
- Next Generation Internal Fixation And Sealant Device
- Next Generation Internal Fixation And Sealant Device Product Overview
- Osteoconductive Resorbable Composite
- Osteoconductive Resorbable Composite Product Overview
- Reinforced Collagen
- Reinforced Collagen Product Overview
- Seal-G
- Seal-G Product Overview
- Seal-G Clinical Trial
- Seal-G MIST
- Seal-G MIST Product Overview
- Seal-G MIST Clinical Trial
- Sealantis Tissue Adhesive
- Sealantis Tissue Adhesive Product Overview
- Site-specific Drug Delivery Adhesive
- Site-specific Drug Delivery Adhesive Product Overview
- Advanced Medical Solutions Group Plc - Key Competitors
- Advanced Medical Solutions Group Plc - Key Employees
- Advanced Medical Solutions Group Plc - Key Employee Biographies
- Advanced Medical Solutions Group Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Advanced Medical Solutions Group Plc, Recent Developments
- Aug 01, 2022: Advanced Medical Solutions Group Announce Directorate Change
- Jun 08, 2022: Advanced Medical Solutions Grp Annual General Meeting
- Jul 07, 2021: Advanced Medical Solutions Group: Half year trading update
- Jun 08, 2021: Advanced Medical Solutions Grp announce Annual General Meeting
- Mar 17, 2021: Advanced Medical Solutions Announces Unaudited Preliminary Results for the year ended 31 December 2020
- Jan 12, 2021: Directorate Change ADVANCED MEDICAL SOLUTIONS GROUP
- Mar 10, 2020: Advanced Medical Solutions Group announces FDA approval of LiquiBand Rapid
- Nov 29, 2019: Advanced Medical Solutions Group : Third party sterilisation failure
- Sep 11, 2019: Advanced Medical Solutions Group: Interim results for the six months ended 30 June 2019
- Jul 30, 2019: Advanced Medical secures US clearance for wound care products
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Advanced Medical Solutions Group Plc Pipeline Products and Ongoing Clinical Trials Overview
- Advanced Medical Solutions Group Plc Pipeline Products by Equipment Type
- Advanced Medical Solutions Group Plc Pipeline Products by Indication
- Advanced Medical Solutions Group Plc Ongoing Clinical Trials by Trial Status
- Advanced Medical Solutions Group Plc, Key Facts
- Advanced Medical Solutions Group Plc, Major Products and Services
- Advanced Medical Solutions Group Plc Number of Pipeline Products by Development Stage
- Advanced Medical Solutions Group Plc Pipeline Products Summary by Development Stage
- Advanced Medical Solutions Group Plc Ongoing Clinical Trials by Trial Status
- Advanced Medical Solutions Group Plc Ongoing Clinical Trials Summary
- Biological Graft - Product Status
- Biological Graft - Product Description
- Dental Collagen - Product Status
- Dental Collagen - Product Description
- Gene-Activated Matrix - Product Status
- Gene-Activated Matrix - Product Description
- Hydrogel - Product Status
- Hydrogel - Product Description
- Large Wounds Closure Device - Product Status
- Large Wounds Closure Device - Product Description
- LiquiBand - Product Status
- LiquiBand - Product Description
- LiquiBand - A Prospective Randomized Controlled Trial Comparing Cyanoacrylate Skin Adhesive with Staple for Surgical Incision Closure after Laparoscopic / Robotic Bowel Resection
- LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device - Product Status
- LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device - Product Description
- LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device - Randomized Single-center Study on Laparoscopic Groin Hernia Repair by a 3D ENDOLAP Visible with and Without LiquiBand Fix 8 Mesh Fixation
- LIQUIFIX Precision Open Hernia Mesh Fixation Device - Product Status
- LIQUIFIX Precision Open Hernia Mesh Fixation Device - Product Description
- LIQUIFIX Precision Open Hernia Mesh Fixation Device - PMCF Study to Evaluate the Safety and Performance of LiquiBand FIX8 Open Hernia Mesh Fixation Device
- Next Generation Internal Fixation And Sealant Device - Product Status
- Next Generation Internal Fixation And Sealant Device - Product Description
- Osteoconductive Resorbable Composite - Product Status
- Osteoconductive Resorbable Composite - Product Description
- Reinforced Collagen - Product Status
- Reinforced Collagen - Product Description
- Seal-G - Product Status
- Seal-G - Product Description
- Seal-G - Seal-G and Seal-G MIST Study for Reinforcement and Protection of Colonic Anastomoses in Subjects Undergoing Colonic Resection
- Seal-G MIST - Product Status
- Seal-G MIST - Product Description
- Seal-G MIST - Seal-G and Seal-G MIST Study for Reinforcement and Protection of Colonic Anastomoses in Subjects Undergoing Colonic Resection
- Sealantis Tissue Adhesive - Product Status
- Sealantis Tissue Adhesive - Product Description
- Site-specific Drug Delivery Adhesive - Product Status
- Site-specific Drug Delivery Adhesive - Product Description
- Advanced Medical Solutions Group Plc, Key Employees
- Advanced Medical Solutions Group Plc, Key Employee Biographies
- Advanced Medical Solutions Group Plc, Subsidiaries
- Glossary
- Advanced Medical Solutions Group Plc Pipeline Products by Equipment Type
- Advanced Medical Solutions Group Plc Pipeline Products by Development Stage
- Advanced Medical Solutions Group Plc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Smith & Nephew Plc
- Artivion Inc
- BSN medical Inc
- ConvaTec Group Plc
- Molnlycke Health Care AB
- 3M Health Care Ltd
- Ethicon US LLC
- Systagenix Wound Management Ltd
- Hollister Inc
